Please login to the form below

Not currently logged in
Email:
Password:

Orion Pharma

This page shows the latest Orion Pharma news and features for those working in and with pharma, biotech and healthcare.

Alzheimer's disease pipeline takes multiple hits

Alzheimer's disease pipeline takes multiple hits

Other AChE inhibitors in phase II development include methanesulfonyl fluoride (SeneXta Therapeutics), ladostigil (Avraham), rilapladib (GlaxoSmithKline) and R-phenserine (QR Pharma). ... 2013). Orion Pharma is developing an oral 2c adrenergic receptor

Latest news

  • 2011 IPA Best of Health Awards winners

    Puffalot', Easyhaler for Orion Pharma, by Langland. 'Rabbit', Easyhaler for Orion Pharma, by Langland. ... Healthcare Professional, Mixed Media Campaign. 'A Little Less Different', Easyhaler for Orion Pharma, by Langland.

  • PM Society Advertising Awards 2010

    Nursing Journal Advertisement. Easyhaler (puffalot) by Langland on behalf of Orion Pharma . Journal Advertisement Campaign. ... Patient Information Campaign. Modigraf Support Pack by Big Pink on behalf of Astellas Pharma Europe.

  • New Accounts, May, 2009, PR & Med Ed

    marketed by Orion Pharma UK.

  • New Accounts: June

    Novo Nordisk. Diabetes insulin portfolio. Diabetes. Woolley Pau. Orion Pharma. Tridestra. ... HRT. Langland. Orion Pharma. Indivina. HRT. Langland. Roche. Avastin. Colorectal cancer.

  • New accounts: May

    Diabetes. Woolley Pau. Orion Pharma. Tridestra. HRT. Langland. Orion Pharma. Indivina.

More from news
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics